Dashboard
Manage Tickers

VALNValneva SE

Nasdaq valneva.com


$ 7.96 $ 0.25 (3.01 %)    

Monday, 10-Jun-2024 09:30:01 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 476.76 $ 6.13 (1.31 %)
DIA $ 387.57 $ -0.28 (-0.07 %)
SPY $ 541.15 $ 4.41 (0.82 %)
TLT $ 92.53 $ 0.69 (0.75 %)
GLD $ 214.71 $ 0.57 (0.27 %)
$ 8.38
$ 7.96
$ 8.09 x 100
$ 0.00 x 0
$ 7.96 - $ 7.96
$ 6.58 - $ 17.05
3,623
na
-6
$ 2.19
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-buy-on-valneva-maintains-26-price-target
HC Wainwright & Co. Reiterates Buy on Valn...
06/04/2024 11:35:03

HC Wainwright & Co. analyst Edward White reiterates Valneva (NASDAQ:VALN) with a Buy and maintains $26 price target.

Core News & Articles
Valneva Announces Phase 2 Trials Of Lyme D...
06/03/2024 15:46:27

Valneva SE (NASDAQ:VALN, PARIS:VLA), a specialty vaccine company, today announced that the results of two Phase 2 clinical tria...

valneva-receives-positive-chmp-opinion-from-ema-for-ixchiq-potential-first-eu-approved-chikungunya-vaccine-decision-expected-in-q3-2024
Valneva Receives Positive CHMP Opinion Fro...
05/31/2024 15:36:42

what-analysts-are-saying-about-valneva-stock
What Analysts Are Saying About Valneva Stock
05/31/2024 14:00:58

hc-wainwright--co-reiterates-buy-on-valneva-maintains-26-price-target
HC Wainwright & Co. Reiterates Buy on Valn...
05/31/2024 13:45:27

HC Wainwright & Co. analyst Edward White reiterates Valneva (NASDAQ:VALN) with a Buy and maintains $26 price target.

hc-wainwright--co-reiterates-buy-on-valneva-maintains-26-price-target
HC Wainwright & Co. Reiterates Buy on Valn...
05/23/2024 10:21:09

HC Wainwright & Co. analyst Edward White reiterates Valneva (NASDAQ:VALN) with a Buy and maintains $26 price target.

valneva-seeks-expanded-use-for-its-chikungunya-vaccine-in-adolescents-with-encouraging-phase-3-data
Valneva Seeks Expanded Use For Its Chikung...
05/13/2024 16:47:36

Valneva released positive Phase 3 data for its single-shot chikungunya virus vaccine in adolescents. The vaccine is also expect...

hc-wainwright--co-reiterates-buy-on-valneva-maintains-26-price-target
HC Wainwright & Co. Reiterates Buy on Valn...
05/13/2024 15:23:16

HC Wainwright & Co. analyst Edward White reiterates Valneva (NASDAQ:VALN) with a Buy and maintains $26 price target.

valneva-reports-further-pivotal-phase-3-data-in-adolescents-for-its-single-shot-chikungunya-vaccine
Valneva Reports Further Pivotal Phase 3 Da...
05/13/2024 06:53:09

Results Intended to Support Filing for Potential Label Extension for Use in Adolescents The latest VLA1553-321 data confirmed t...

cracking-the-code-understanding-analyst-reviews-for-valneva
Cracking The Code: Understanding Analyst R...
05/08/2024 13:00:54

hc-wainwright--co-reiterates-buy-on-valneva-maintains-26-price-target
HC Wainwright & Co. Reiterates Buy on Valn...
05/08/2024 10:29:49

HC Wainwright & Co. analyst Edward White reiterates Valneva (NASDAQ:VALN) with a Buy and maintains $26 price target.

valneva-for-2024-expects-total-revenues-of-170m-190m-and-rd-investments-between-60m-75m
Valneva For 2024 Expects Total Revenues Of...
05/07/2024 05:47:14

2024 financial guidance confirmed Expected total revenues between €170 million and €190 million, including: €160 million...

valneva-q1-revenue-328m-down-from-335m-yoy-net-profit-589m-up-from-net-loss-181m-yoy
Valneva Q1 Revenue €32.8M Down From €33.5M...
05/07/2024 05:46:26

Net Profit of €58.9 million, reflecting PRV sale

valneva-announces-the-initiation-of-phase-1-trial-of-second-generation-zika-vaccine-candidate
Valneva Announces The Initiation Of Phase ...
03/26/2024 07:14:09

The randomized, placebo-controlled, Phase 1 trial, VLA1601-102, is planned to enroll approximately 150 participants aged 18 to ...

what-analysts-are-saying-about-valneva-stock
What Analysts Are Saying About Valneva Stock
03/22/2024 18:01:04

guggenheim-maintains-buy-on-valneva-lowers-price-target-to-17
Guggenheim Maintains Buy on Valneva, Lower...
03/22/2024 17:59:28

Guggenheim analyst Evan Wang maintains Valneva (NASDAQ:VALN) with a Buy and lowers the price target from $18 to $17.

hc-wainwright--co-reiterates-buy-on-valneva-maintains-26-price-target
HC Wainwright & Co. Reiterates Buy on Valn...
03/21/2024 10:42:02

HC Wainwright & Co. analyst Edward White reiterates Valneva (NASDAQ:VALN) with a Buy and maintains $26 price target.

valneva-to-present-on-its-single-shot-chikungunya-vaccine-ixchiq-participate-in-multiple-events-at-the-24th-world-vaccine-congress-in-washington-dc
Valneva To Present On Its Single-Shot Chik...
03/21/2024 06:10:20

valneva-raised-2024-product-sales-guidance-to-160m-180m-prior-150m-180m-sees-total-revenues-of-170m-190m
Valneva Raised 2024 Product Sales Guidance...
03/20/2024 06:32:11

Updated FY 2024 guidance Valneva raises its 2024 product sales4 guidance to between €160 million and €180 million due to an ...

valneva-fy23-revenue-1537m-down-from-3613m-yoy-net-loss-1014m-compared-to-1433m-yoy
Valneva FY23 Revenue €153.7M Down From €36...
03/20/2024 06:25:29

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)